Related Experiment Video
Updated: May 12, 2026
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
EphB4 cellular kinase activity assayed using an enzymatic protein interaction system
Tom Wehrman1, Mimi Nguyen, Wei Feng
1DiscoveRx Corporation, Fremont, California 94538, USA. twehrman@discoverx.com
Abstract:
Receptor tyrosine kinases (RTKs) are important players in various cellular processes, including proliferation, migration, metabolism, and neuronal development. EphB4 RTK is essential for the development of a functional arterial-venous network in embryonic and adult neoangiogenesis. To develop novel inhibitors of EphB4 that might have applications in severe diseases like cancer and retinopathies, assays need to be in place that resemble, in a most physiological fashion, the activation and downstream function of the kinase. In addition, such assays need to be amenable to high-throughput screening to serve efficiently the modern drug discovery processes in the pharmaceutical industry. The authors have developed an enzyme fragment complementation assay that measures the interaction of a downstream docking protein to the activated and phosphorylated full-length EphB4 kinase in cells. The assay is specific, robust, and amenable to miniaturization and high-throughput screening. It covers most steps in the activation process of EphB4, including ligand binding, autophosphorylation, and docking of a downstream interactor. This assay format can be transferred to other RTKs and adds an important cell-based kinase assay option to researchers in the field.
Insights
Researchers developed a new cell-based assay to study EphB4 receptor tyrosine kinase (RTK) activation. This high-throughput screening method aids in discovering drugs for diseases like cancer and retinopathies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- Receptor tyrosine kinases (RTKs) regulate critical cellular functions, including proliferation and development.
- EphB4 RTK plays a vital role in forming vascular networks during embryonic development and adult angiogenesis.
- Targeting RTKs like EphB4 is crucial for developing therapies for diseases such as cancer and retinopathies.
Purpose of the Study:
- To develop a physiological, cell-based assay for measuring EphB4 kinase activation and downstream interactions.
- To create a high-throughput screening (HTS) compatible assay for efficient drug discovery targeting EphB4.
- To provide a robust tool for researchers studying EphB4 signaling pathways.
Main Methods:
- Development of an enzyme fragment complementation assay (ECA).
- The assay measures the interaction between activated, phosphorylated EphB4 and a downstream docking protein in intact cells.
- Assay validation for specificity, robustness, and amenability to miniaturization and HTS.
Main Results:
- The developed ECA accurately reflects EphB4 activation, including ligand binding, autophosphorylation, and substrate docking.
- The assay demonstrates specificity and robustness, suitable for HTS.
- The assay format is adaptable for other RTKs, expanding its utility.
Conclusions:
- A novel, cell-based ECA has been successfully developed for EphB4 kinase.
- This assay is a valuable tool for drug discovery and research into EphB4-related diseases.
- The assay's adaptability offers a versatile option for studying various RTKs.
